ArticleEndocrinology and metabolism (Seoul, Korea)2021

The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE-/-FXR-/- Mice.

Yenna Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.